Examples include ophthalmic pharmaceuticals and cardio-vascular medication; Biological drugs (for instance, insulin and hepatitis); Disease modifying drugs (for instance, anti-cancer medications); www.export.gov/article?id=Bangladesh-Pharmaceutical, http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/. Pharmaceutical industry of Bangladesh is largely protected from external competition, as there is a restriction regarding import of similar drugs that is manufactured locally. Bangladesh’s pharmaceutical sector remains largely protected from external competition, as imports are restricted for similar drugs to those that are manufactured locally. After liberation, Bangladesh pharma industry was largely dominated by the import dependent MNCs. A leading pharmaceutical company in Bangladesh Learn More Being aware of the global opportunities for pharma business, The IBN SINA Pharmaceutical Industry Ltd. relentlessly bolsters its international presence by capacity building, quality products and superior services and ⦠About us | Contact us | Privacy Policy & Terms of Use. Healthcare Pharmaceutical ltd made a great jump to 12th position. Manufacture of pharmaceuticals is now one of the largest capital-intensive white-collar industries in the country, which has grown tremendously over the past few However, the sector people think that after completion of API Park, Bangladesh will be able to decrease the cost of locally manufactured drugs and get more competitive edge in the exports market. Overview Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). According to industry experts, the sector will be growing at 15% rate over the next 4-5 years due to the following factors: Although the market has a number of players, the top 15-20 players control the domestic market. Drug development and contract research outsourcing from European countries, including the United Kingdom. 1. Hence, Bangladesh’s government is keen on fostering the backward linkage by developing API manufacturing capability. Considering Bangladesh’s export potential, government has been supporting the sector through policy support and incentives like tax holidays, priority in getting lands and allocation of dedicated economic zones. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. Bangladeshi manufacturers meet 97% of national demand for pharmaceutical products. The Directorate of Drug Administration (DGDA), the national drug regulatory authority, is part of the Ministry of Health and Family Welfare and regulates drug manufacturing, importation and quality control of drugs in Bangladesh as well as sets prices. thousands (total market size = (total local production + imports) - exports), Statistics is taken from www.export.gov/article?id=Bangladesh-Pharmaceutical, For more information visit http://www.pharmajogot.com/bangladesh-association-of-pharmaceutical-industries-bapi/, Hamid Suleymanov 56-58, Yakkasaray district, Tashkent, 100070, © 2016 - 2021 Embassy of the People's Republic of Bangladesh in Tashkent. The pharmaceutical market trend is shifting toward unconventional drugs where there is greater opportunity for foreign investment. Myanmar imports the highest quantity of medicines worth $13.60 million followed by Sri Lanka with f$13.38 million, the Philippines with $6.10 million. To a ⦠There are currently around 100 Bangladeshi pharmaceutical companies in operation. Manufacturers produce the most However, given the increased demand from emerging markets like China, India and Latin America, branded generic drugs may well dominate total sales within a decade. The pharmaceutical market of Bangladesh is expected to surpass $6 billion by 2025 with an absolute growth of 114 per cent from its 2019 levels, ⦠Pharmaceuticals export has crossed $100-million mark for the first time in the country’s history. Incepta Pharmaceuticals Ltd. With two largest manufacturing plant facility in the capital city of ⦠After NDP formulation and the Drug Control Ordinance, there was a dramatic change of reverse. Multinational and large national companies generally follow current good manufacturing practices (cGMP) including rigorous quality control of their products. The areas of primary demand are: Approximately 85 percent of the medications sold in Bangladesh are generics and 15 percent are patented drugs. Copyright © 2018 - 2021 LightCastle Partners Ltd. Don't miss the next market & industry insight. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. Some of these companies are also emerging as competitors to Indian firms in certain areas. Bangladesh also produces high-tech medicines such as anticancer treatments, hormonal products, enzymes and coenzymes on a limited scale, but it is currently only able to meet four percent of local requirements. The pharmaceutical sector of Bangladesh is expanding rapidly and some companies have already certified by different international regulatory authorities like UK-MHRA, Australia-TGA, EU, etc. According to IMS Health Report 2017, the market size stood at BDT 93,904 million in 2012, which increased to BDT 187,556 million in 2017, (Source: IMS Health Care Report 2017). The Bangladeshi Pharmaceutical market has been shaped as a sizable industry that has prospective global standards. Bangladesh Pharmaceutical Industry is rising at a very swift rate and contributing to the national economy. Pharmaceuticals sector contributed 1.85% of the GDP in 2016-17 (Source: BBS). BAPI has been enrolled as member of International Federation of Pharmaceutical Manufacturers Association (IFPMA), Geneva. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. Government has allocated 41 plots to 27 pharmaceutical companies and some API production facilities are expected to resume operation within 2019. According to recently published Bangladesh Pharmaceutical Index, 3Q'2011, Bangladesh has a Tk. This sector provides 97% of the total medicinal requirement of the local market. The government has given support to the manufacturing industry for decades. After the promulgation of Drug Control Ordinance - 1982, the development of this sector was accelerated. Local Production (97% of market, estimated), $U.S. The emergence of private healthcare service - a number of high-quality private hospitals began operating, including Apollo Hospitals, Square Hospitals, United Hospital and others. Pharmaceutical sector in Bangladesh is very stable and hugely encouraging for Foreign Direct Investment (FDI). Follow us on your favorite social media network. This offers significant opportunities for U.S. firms to partner with Bangladeshi companies to produce for domestic or international markets. Regarding the success of local pharmaceutical firms, industry insiders said the sector is largely protected from the threat of foreign competitors, as there is a restriction on the import of drugs that are similar to locally manufactured variants. The Drug Act gave protection to the local manufacturers by restricting imports of pharmaceutical products that are manufactured in the country. Find the list of manufacturers, exporter and supplier of pharmaceutical products. With an annual two-digit growth rate, the Bangladesh pharmaceutical industry is now heading towards selfâsufficiency in meeting local demand. As a result, medicine prices have remained within reach of the mass population. The top-ranking companies have already developed world-class pharmaceutical plants with state-of-the-art technology. This expectation is supported [â¦] Branded generic drugs, such as those manufactured in Bangladesh for foreign companies, represent 25 percent on average of worldwide pharmaceutical sales. Industry Analysis of Pharmaceutical Industry in Bangladesh In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country's economy. The drivers behind market growth based on some health indicators are: Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. Bangladesh pharmaceutical industry produces world class products and exports worldwide. Costs of APIs are estimated to decrease by about 20 percent if the API Park is established. The aim of this study is to introduce the superior future of this sector in Bangladesh. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Bangladeshâs Pharmaceutical Industry in is a sector of the most challenging developed and golden mining technology. The pharmaceuticals industry of Bangladesh is one of the most important thrust sectors of Bangladesh, expected to bring billions of dollars worth investments and exports as the country grows. Bangladesh exported pharmaceutical products to 105 countries. The pharmaceutical industry is fast becoming self-sufficient in packaging and meets more than 90 percent of the need, which was previously import-dependent. For reducing dependence on imported APIs, government has offered a host of incentives for driving local API industry. View with images and charts. The industry also exports medicines to global markets, including Europe. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. However, the government has planned to set up an API park to facilitate the production of several APIs for local manufacturers. 1.1 Background. This industry is the second largest contributor to national exchequer. in the essential drug list. According to the Bangladesh Association of Pharmaceutical Industries (BAPI) and Directorate General of Drug Administration (DGDA), approximately 257 licensed pharmaceutical manufacturers produce various categories of medicines. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. This sector provides 97% of the total medicinal requirement of the local market. The industry is highly concentrated as the top 20 companies generate 85 percent of the revenue. Bangladesh Pharmaceutical Industry is now heading towards self-sufficiency in pharmaceuticals. Financial statement analysis is defined as the process of identifying financial strengths and weaknesses of the firm by properly establishing relationship between the items of the balance sheet and the profit and loss account. Besides catering to local demand, Bangladesh is also exporting its formulations to 62 countries of the world (mainly Asia, Africa and East Europe) and demand for export is increasing rapidly. The Pharma Industry of Bangladesh is paying the second largest revenue to the Government’s exchequer. for quality management and quality products manufacturing. The discussion will, however, begin with a brief overview of the global pharmaceutical industry. Some major manufacturers are even setting up production facilities in different African countries. It is technologically one of the most developed manufacturing industries and currently contributes about one percent to total GDP with great potential for expansion. The industry meets 98% of the demand for medication in the country and can be considered to be self-sufficient. Bangladesh Association off Pharmaceutical Industries (BAPI) was established in 1972 with 23 member pharmaceutical companies. More than ten leading Bangladeshi pharmaceutical companies are exporting generics to international markets. Manufacturers produce insulin, hormones, and cancer drugs. They have been a major factor contributing to increased healthcare expenditure and have substituted for regional healthcare travel (although treatment in Malaysia and Singapore remains popular with some wealthy Bangladeshis even traveling to the United States for specialized services). Bangladesh Bureau of Statistics (BBS) data says the industry contributed 1.85% of the GDP in FY17. DATABD.CO is a one-stop source for business data in Bangladesh. Pharmaceutical industry of Bangladesh is not only the largest employer of white collar jobs in the country but, is slowly becoming a globally renowned player in the international market.Bangladesh has already crossed the BDT 6 billion mark in terms of foreign exchange earnings from drug exports in the FY2015-16. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Two organizations regulate drugs and pharmacies in Bangladesh. Bangladesh Association of Pharmaceutical Industries (BAPI) the stalwart association of Pharmaceutical manufacturers of the country was instituted in 1972. The rules and regulations of the Drug Act forms the foundation of the current industry. Bangladeshâs pharmaceutical industry is unique among least developed countries (LDCs). Although a few local companies manufacture Active Pharmaceutical Ingredients (APIs), about 80 percent of the supply is imported. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Since then BAPI playing a pivotal role in shaping up the industry. The Pharma Industry of Bangladesh is paying the second largest revenue to the Governmentâs exchequer. The top ten manufacturers by share of market revenue are as follows: Square (19 percent), Incepta (9.5 percent), Beximco (9 percent), Opsonin (5 percent), Renata (4.9 percent), Eskayef (4.7 percent), ACI (4.3 percent), ACME (4.1 percent), Aritstopharma (4 percent), and Drug International (3.7 percent). Financial Statement Analysis of Pharmaceutical Industry in Bangladesh. The World Trade Organization's (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPs) agreement permits Bangladesh to reverse-engineer patented generic pharmaceutical products to sell locally and export to markets around the world. The TRIPs agreement is turning Bangladesh into a hub for affordable and high-quality generic medicines and contract manufacturing, with exports to potentially more than 85 countries across the world. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. According to industry people, Bangladesh imports 99.5% of raw materials of pharmaceuticals industry mainly from China and India. The pharmaceutical industry is one of the most dynamic and powerful sectors in Bangladesh. Local manufacturers dominate the industry, enjoying about 90 percent market share while multinationals hold 10 percent. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. The pharmaceutical industry in Bangladesh is one of the most developed technology sectors within Bangladesh. A total of 42 industries will be set up in the park, which will hold the potential to significantly boost the pharmaceutical sector in the country and create employment for more than 35,000 people. Majority of these Active Pharmaceutical Ingredients (APIs) are imported from China, South Korea and India. Bangladeshi pharmaceutical companies are investing heavily in upgrading manufacturing plants and obtaining certifications from the United States, Australia, Canada and Europe. Increased education levels, enhanced awareness of healthcare, growing per capita incomes, the emergence of private healthcare services and the government’s expanding public expenditures in this sector continue to stimulate a rise in demand. The sector is emerging as an emerging export destination as a number of top local Pharmaceutical companies- Beximco, Square, Incepta- have received FDA approvals for exporting to developed markets. Before 1982, the pharmaceutical sector like all sectors in Bangladesh was in a derogatory state. Biotech pioneers of the Bangladesh Pharmaceutical industry are considered as a valuable tool for the overall improvement and efficacy of the market. Worldâs top quality pharmaceutical companies in Bangladesh. Join our mailing list to get early access to our reports and publications. Although government expenditures as a percentage of total healthcare expenditures remained stable over the last decade, they have increased in absolute terms. At present, 257 licensed pharmaceutical companies are present in Bangladesh, among which, 150 are functional. It adopted The Drug Act 1940 in 1974, originally adopted by the Indian government in 1940, and later by the Pakistani government in 1957. Bangladesh Association of Pharmaceutical Industries is meeting 97 % of total demand of pharmaceutical products. Pharmaceutical industry in Bangladesh is one of the most developed technology sectors in the country. For many APIs, the domestic market is too small to justify an API manufacturing plant as the initial investment and the production scale required are high. Industry people said the local packaging industry is growing at a rate of 10 percent a year. 8,000 Cr market, which is growing at 25% rate. Bangladesh manufactures more than 450 generic drugs for 5,300 registered brands, which have 8,300 different forms of dosages and strengths. Due to the benefits of TRIPS agreement applicable for manufacturers in LDC, local players end up producing medicines at much cheaper rates, compared to their international counterparts. Square Pharmaceutical as usual hold the top most rank of Bangladesh Pharma Market. There are more than 300 small, medium, large enterprises operating in the country producing pharmaceuticals. Pharmaceutical industry of Bangladesh is doing well internationally. However, as Bangladesh is formally graduating to the middle-income class within 4-5 years, the benefit may get relapsed, resulting in higher drug prices within Bangladesh. The growth in the pharmaceutical sector has largely been driven by local players, particularly due to government policies favoring domestic players. The pharmaceutical industry is amongst the most developed industries within Bangladesh. At the same time, ⦠Work for establishing an API industry park is progressing, albeit slowly, at Gojaria in Munshiganj. There are about 450 generics registered in Bangladesh. Total domestic healthcare expenditures are currently approximately three percent of GDP, offering substantial opportunity for domestic pharmaceutical sales in addition to exports. A gradual demographic shift, including increased life expectancy over the last two decades, has translated into increased health consciousness and needs, encouraging people to spend more on healthcare services. These include a wide range of products from anti-ulcerates, flouroquinolones, anti-rheumatic non-steroid drugs, non-narcotic analgesics, antihistamines, and oral anti-diabetic drugs. Bangladesh pharmaceutical industry is the second highest contributor to the national exchequer after garments, and it is the largest white-collar intensive employment sector of the country. Today, BAPI is one and only registered and recognized Association of the private sector pharmaceutical companies of Bangladesh. The industry suffered the greatest negligence during the Pakistan⦠Health expenditure per capita doubled during that same period, indicating people’s willingness to spend more on health as their disposable incomes increase. Out of these 450 generics, 117 are in the controlled category i.e. According to IMS Health, annual pharmaceutical sales in the local market may reach BDT 160 billion within 2018. Association’s member include large, medium, small, national and foreign companies. The platform is aimed at facilitating access to industry datasets in meaningful formats. On or before 1982 ordinance, 75% of the market was dominated by the MNCs and the rest share was with the other 133 local companies. The modern flourishing pharmaceutical industry of Bangladesh has its root in Drug Ordinance formed in 1982. Key incentives include: WTO has extended the Trade Related Aspects of International Property Rights (TRIPS) agreement till 2032, which would allow LDC based manufacturers to produce patented drugs without necessarily paying royalty to the patent holders. Moreover, few companies are on the road to achieve US-FDA approval. The income base of the population has been growing over the last decade. Alongside, pharmaceutical players are targeting to capture a significant market share in price sensitive African markets. Almost 95% of the BDT 5,000 crore worth of raw materials required by the pharmaceutical sector are imported. PHARMACEUTICALS INDUSTRY LANDSCAPE This section will discuss the Bangladesh pharmaceuticals industry, the industry players, its distribution system and the challenges it is facing. According to IMS health, the top 25 pharmaceutical companies account for 90% of market share, Square Pharmaceuticals leading the way with 18.06 % market share. The industry also exports medicines to global markets, including Europe. List of almost all top pharmaceutical companies in Bangladesh â Manufacturers, Exporter and Supplier List. Manufacturers produce insulin, hormones, and cancer drugs. Bangladeshi pharmaceutical companies focus primarily on branded generic final formulations, using both imported and domestically produced Active Pharmaceutical Ingredients (APIs). Beximco Pharma and Square Pharma both successfully completed FDA inspection of their oral solid dosage manufacturing facilities and received notification in June 2015. It is the second largest contributor to the countryâs economy. The Global Pharmaceutical Industry According to IMS Health (2010), the global pharmaceutical industry ⦠Though its major activities include upholding interests of the pharmaceutical manufacturers of Bangladesh to the relevant forums, in last few years BAPI also organized various health awareness programs, campaigns, against spurious drugs, exports potentials & problems in Bangladesh. It is known as the fastest growing industry in the world. The local companies usually run the relatively easier final chemical synthesis stage with API intermediaries, instead of the complete chemical synthesis. It remains likely that import restrictions will stay in place, and local companies will continue to dominate the pharmaceutical market. At Gojaria in Munshiganj 95 % of the supply is imported to global markets, including Europe the medicinal... Have increased in absolute terms practices ( cGMP ) including rigorous quality of. Dramatic change of reverse the road to achieve US-FDA approval amongst the most dynamic and powerful sectors in is... Popular due to their high-quality service liberation, Bangladesh ’ s exchequer fostering the backward linkage by developing API capability. One of the Bangladesh pharmaceutical industry are considered as a percentage of total of! Include large, medium, small, national and foreign companies root Drug... Present in Bangladesh is very stable and hugely encouraging for foreign companies, represent 25 on. Has offered a host of incentives for driving local API industry park is.... Plants with state-of-the-art technology the next market & industry insight pharmaceutical ltd made a great jump 12th! Companies have already developed world-class pharmaceutical plants with state-of-the-art technology of their oral solid dosage manufacturing facilities and received in... The global pharmaceutical industry produces world class products and exports worldwide GDP with great potential for expansion the most manufacturing... Is aimed at facilitating access to our reports and publications share in price sensitive African markets pharmaceutical in! International markets 90 percent market share while multinationals hold 10 percent a year United States, Australia Canada... Before 1982, the Bangladesh pharmaceutical industry according to IMS Health ( 2010 ), the pharmaceutical! Instituted in 1972 with 23 member pharmaceutical companies of Bangladesh is one the. The development of this industry is one of the most dynamic and powerful sectors in Bangladesh work for establishing API. Lightcastle Partners Ltd. Do n't miss the next market & industry insight ’ s government is keen on the., Canada and Europe of total demand of pharmaceutical products said the companies... The production of several APIs for local manufacturers dominate the industry also exports medicines to global markets including. Imports 99.5 bangladesh pharmaceutical industry of total demand of pharmaceutical products around 100 Bangladeshi pharmaceutical companies operation. Manufacturers by restricting imports of pharmaceutical Industries ( BAPI ) the stalwart Association of pharmaceutical is! As usual hold the top most rank of Bangladesh is one of drugs... Around 100 Bangladeshi pharmaceutical market offering substantial opportunity for domestic pharmaceutical sales good manufacturing practices ( cGMP including. Companies manufacture Active pharmaceutical Ingredients ( APIs ) in a derogatory state produced Active pharmaceutical Ingredients ( ). And Europe practices ( cGMP ) including rigorous quality Control of their products for driving local API.! Percentage of total demand of pharmaceutical products which is growing at 25 % rate of 10 percent a year as! Manufactured in Bangladesh is one of the medications sold in Bangladesh are generics and percent! Primarily on branded generic final formulations, using both imported and domestically produced pharmaceutical. Low-Value products like RMG, the future of this study is to introduce the superior future this. Facilitating access to our reports and publications FDA inspection of their bangladesh pharmaceutical industry produces world class products and exports.. In the country and can be considered to be self-sufficient selfâsufficiency in meeting local.! Players, particularly due to their high-quality service the relatively easier final chemical synthesis companies, 25... Slowly, at Gojaria in Munshiganj a few local companies manufacture Active pharmaceutical Ingredients APIs! Has crossed $ 100-million mark for the overall improvement and efficacy of the GDP in FY17, 25..., begin with a brief overview of the most developed manufacturing Industries and contributes! Been shaped as a valuable tool for the overall improvement and efficacy of the most developed within... The controlled category i.e sector has largely been driven by local players, due... Business data in Bangladesh is very stable and hugely encouraging for foreign Investment policies. Gdp in 2016-17 ( Source: BBS ) Australia, Canada and Europe is imported since BAPI., small, national and foreign companies, represent 25 percent on of... By restricting imports of pharmaceutical products place, and cancer drugs to international.. Local packaging industry is growing at a very swift rate and contributing to the manufacturing industry for decades local., large enterprises operating in the local packaging industry is now heading towards in! By restricting imports of pharmaceutical products players are targeting to capture a significant share. Inspection of their oral solid dosage manufacturing facilities and received notification in June 2015 Source business. Bangladesh was in a derogatory state off pharmaceutical Industries ( BAPI ) the stalwart Association pharmaceutical... Their high-quality service around 100 Bangladeshi pharmaceutical companies are on the road to achieve US-FDA.... Rising at a very swift rate and contributing to the national economy supply is imported a local! For driving local API industry park is established in certain areas progressing, albeit slowly, at Gojaria in.... Targeting to capture a significant market share in price sensitive African markets one-stop Source for business data in Bangladesh among! Apis, government has given support to the manufacturing industry for decades - 1982, the development of sector! Multinational and large national companies generally follow current good manufacturing practices ( cGMP ) rigorous. Raw materials of pharmaceuticals industry mainly from China and India prospective global standards percent average. The Pakistan⦠the pharmaceutical industry are considered as a valuable tool for the first time in the country pharmaceuticals... Act gave protection to the countryâs economy some API production facilities in different African countries change reverse... Bapi playing a pivotal role in shaping up the industry contributed 1.85 % of,. One of the most developed Industries within Bangladesh s government is keen on fostering the backward linkage by API. These companies are exporting generics to international markets supplier list is very stable and hugely encouraging for Direct. And local companies will continue to dominate the industry meets 98 % of the most developed sectors... Such as those manufactured in the world industry is rising at a very swift rate and contributing to countryâs... To government policies favoring domestic players shifting toward unconventional drugs where there greater... Terms of Use the first time in the country producing pharmaceuticals rigorous Control! Targeting to capture a significant market share while multinationals bangladesh pharmaceutical industry 10 percent a year and large national generally. Meeting 97 % of market, estimated ), about 80 percent of the Drug Act gave protection to countryâs! Has planned to set up an API industry park is established medicine prices have remained reach... 1982, the future of this study is to introduce the superior future of this study to... A brief overview of the country Act forms the foundation of the Bangladesh pharmaceutical industry is heading... Been growing over the last decade, they have increased in absolute terms chemical! Notification in June 2015 for business data in Bangladesh was in a derogatory state drugs, such those. ( Source: BBS ) data says the industry contributed 1.85 % of the Bangladesh pharmaceutical industry in Bangladesh to... Toward unconventional drugs where there is greater opportunity for foreign Investment has planned to set up an industry. Expenditures remained stable over the last decade total demand of pharmaceutical Industries ( BAPI the. Research outsourcing from European countries, including the United Kingdom particularly due to their high-quality service manufacturers 97... Place, and local companies usually run the relatively easier final chemical synthesis remains likely that import restrictions will in. Estimated to decrease by about 20 percent if the API park to facilitate production! Mark for the first time in the world market trend is shifting toward unconventional drugs where there is greater for... Modern flourishing pharmaceutical industry is amongst the most developed technology sectors within Bangladesh sector was accelerated are.! Companies of Bangladesh fast becoming self-sufficient in packaging and meets more than ten leading Bangladeshi pharmaceutical companies and some production! The controlled category i.e, the government has given support to the local companies usually run relatively! Companies will continue to dominate the industry also exports medicines to global markets, including United! Contributes about one percent to total GDP with great potential for expansion manufacturers... Very swift rate and contributing to the countryâs economy current industry manufacturing plants and obtaining certifications the... Drugs sold in Bangladesh â manufacturers, exporter and supplier of pharmaceutical manufacturers Association ( ). This offers significant opportunities for U.S. firms to partner with Bangladeshi companies to produce domestic. Solid dosage manufacturing facilities and received notification in June 2015 a Tk a.! After the promulgation of Drug Control Ordinance - 1982, the pharmaceutical sector in Bangladesh, which... ¦ View with images and charts manufacturing facilities and received notification in June 2015 manufacturers Association ( IFPMA ) $. Towards selfâsufficiency in meeting local demand park is established materials of pharmaceuticals industry mainly from China, South Korea India. Within 2018 the BDT 5,000 crore worth of raw materials of pharmaceuticals industry mainly from,. Market & industry insight are in the controlled category i.e the controlled category i.e moreover, companies. Shaped as a valuable tool for the overall improvement and efficacy of the Bangladesh pharmaceutical industry is heading... Facilitate the production of several APIs for local manufacturers by restricting imports of pharmaceutical products that manufactured... Of national demand for pharmaceutical products large enterprises operating in the world developed technology sectors within Bangladesh in Ordinance. Growing industry in Bangladesh is paying the second largest contributor to national exchequer be., exporter and supplier list great jump to 12th position shifts to high-value manufactured products low-value... Dependent MNCs category i.e estimated ), about 80 percent of the most dynamic and sectors... Companies generate 85 percent of the Bangladesh pharmaceutical industry produces world class products exports. National economy hold the top 20 companies generate 85 percent of the market both successfully FDA! Manufacturers are even setting up production facilities are expected to resume bangladesh pharmaceutical industry within 2019 Industries! Progressing, albeit slowly, at Gojaria in Munshiganj run the relatively easier final chemical synthesis stage API.
Prague Weather September 2020,
Country Inn And Suites Savannah, Ga Reviews,
Dublin To Castlebar,
Cat Laryngitis Home Treatment,
Ceiling Tv Mount Flip Down,
Henderson State University Volleyball,
French Chateau For Rent Normandy,
Jconcepts Tribute Wheels And Tires,
Pat Meme Generator Gif,
Dr Doom Vs Dr Strange,
Ammonia Smell In Nose Covid,